Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of penicillin, gentamicin, and amoxicillin represents an antibiotic regimen that has been studied and used in various clinical contexts. This combination leverages the synergistic effects between beta-lactam antibiotics (penicillin and amoxicillin) and aminoglycosides (gentamicin). ## Description This is a combination antibiotic therapy that pairs beta-lactam antibiotics (penicillin and amoxicillin) with an aminoglycoside (gentamicin). The combination demonstrates synergistic effects against various bacterial infections, particularly in treating severe infections like pneumococcal pneumonia, enterococcal infections, and neonatal sepsis[1][6][8]. Beta-lactam antibiotics cause non-fatal damage to bacterial cell walls, which promotes aminoglycoside entry into bacteria and enhances their killing ability[10]. This synergistic mechanism allows for more effective bacterial clearance, expanded treatment scope, and potentially reduced development of antibiotic resistance[10]. The World Health Organization recommends gentamicin in combination with benzylpenicillin, ampicillin, or amoxicillin as first-choice treatment for sepsis in neonates and children[5]. Studies have shown that oral amoxicillin plus gentamicin regimens may be superior to procaine-penicillin plus gentamicin regimens for treating young infants with possible serious bacterial infections when hospital referral is not feasible[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on penicillin + gentamicin + amoxicillin.